Literature DB >> 22569395

Unusual markings on an intraocular lens postoperatively.

Anjali Mehta.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22569395      PMCID: PMC3361829          DOI: 10.4103/0301-4738.95887

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
Dear Editor, The clear refractive surface of intraocular lenses (IOLs) may be clouded by inflammatory deposits, cells (posterior capsular opacification) or denaturation of the lens material itself. Our patient had highly unusual deposits on the lens postoperatively. Several factors causing opacification of intraocular lenses are discussed. A 50-year-old lady had painless, progressive diminution of vision and sensation of glare since eight years. She had bilateral, small, central posterior subcapsular cataracts of Grade 2 density. Her best corrected visual acuity was 20/80 and 20/40, respectively. Fundii were normal. She underwent phacoemulsification surgery in her right eye and a foldable IOL, Aquafold (model CB F32 UVA, Omni Lens Pvt. Ltd.) was implanted through its circular plastic cartridge. On the first postoperative day, the patient had significant anterior chamber reaction, with Grade 4+ cells and trace hypopyon. The cornea was clear. Her vision was 20/40. The fundus appeared normal. The reaction subsided with medication, over a period of two to three days, with cells decreasing to 2+ with no hypopyon. At this stage, seven to nine thin, elongated, oval-shaped markings were clearly noticeable on the posterior surface of the lens optic. These were between 3-7 mm long, about 1-3 mm wide, and arranged parallel to one another [Fig. 1] in a horizontally slanting direction across the back surface of the optic. These lines were perpendicular to the direction of the lens folding in the cartridge, not along it. These were not typical scratch marks or folding lines. They appeared to be deposits. Unlike typical inflammatory deposits which tend to be scattered and diffuse, they had a precise linear arrangement.
Figure 1

Unusual parallel markings on the posterior surface of the intraocular lens seen postoperatively

Unusual parallel markings on the posterior surface of the intraocular lens seen postoperatively At one-month follow-up, these markings on her lens persisted, unchanged. Her BCVA was 20/25. However, at a fourth-month follow-up visit, there was no trace left of these deposits/lines. They had disappeared totally [Fig. 2].
Figure 2

Clear lens surface at four months’ follow-up: Complete disappearance of posterior surface markings

Clear lens surface at four months’ follow-up: Complete disappearance of posterior surface markings Postoperative causes of opacification include inflammatory/fibrin deposits and posterior capsular opacification. Lenticular deposits may occur in predisposed eyes; such as those with asteroid hyalosis[1] or uveitis, or in otherwise healthy eyes which have undergone routine cataract surgery. This may be due to an inherent problem with the lens material itself or the structure or composition of the lens injector used.[2-4] Intraocular lens deposits have been well studied and classified by some.[5] In instances where the lens deposits interfere with vision significantly, the lens needs explantation. Such explanted lenses have been studied using methods like staining, transmission electron microscopy and elemental analysis. In almost all cases, the deposits were found to be calcium salts.[235] The deposits in our patient did not fit clearly into any of the described categories. The lens markings were perpendicular to the direction of the folded lens in the injector barrel making this an unlikely cause. The deposits may have been inflammatory in nature or a very low-grade toxic anterior segment syndrome. However, inflammatory deposits are rarely ever found in such precise parallel lines and they usually either disappear in a few days after anti-inflammatory medication or form permanent membranes. It is possible that some viscoelastic/ ethylene oxide (ETO) residue remained on parts of the lens surface and these areas then became a nidus for a mild secondary calcification. In this case their disappearance is most unusual.
  5 in total

1.  Investigation and management of an epidemic of Hydroview intraocular lens opacification.

Authors:  R W Altaie; T Costigan; S Donegan; P O'brien; U Mahmood; A J Bogdan; S Beatty
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-11       Impact factor: 3.117

2.  Linear deposits on the surfaces of intraocular lenses implanted through a hexagonal cartridge which mimic scratches/cracks on the lenses.

Authors:  G Kleinmann; A L Marcovich; D J Apple; N Mamalis
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

3.  Late postoperative opacification of a hydrophilic acrylic (hydrogel) intraocular lens: a clinicopathological analysis of 106 explants.

Authors:  Irmingard M Neuhann; Liliana Werner; Andrea M Izak; Suresh K Pandey; Guy Kleinmann; Nick Mamalis; Thomas F Neuhann; David J Apple
Journal:  Ophthalmology       Date:  2004-11       Impact factor: 12.079

4.  A new classification of calcification of intraocular lenses.

Authors:  Irmingard M Neuhann; Guy Kleinmann; David J Apple
Journal:  Ophthalmology       Date:  2007-05-11       Impact factor: 12.079

5.  Surface calcification of silicone plate intraocular lenses in patients with asteroid hyalosis.

Authors:  Laura Foot; Liliana Werner; James P Gills; David W Shoemaker; Paul S Phillips; Nick Mamalis; Randall J Olson; David J Apple
Journal:  Am J Ophthalmol       Date:  2004-06       Impact factor: 5.258

  5 in total
  1 in total

Review 1.  Etiology, pathogenesis, and management of acute intraocular lens opacification: a systematic review.

Authors:  Bita Momenaei; Mohammad Reza Akbari; Seyed Ali Tabatabaei; Mohammad Soleimani; Mahdi Soleymanzadeh; Kaveh Fadakar; Ahmed Alshaheeb; Mahtab Malekpour Khazari; Yasaman Vaseghi; Kasra Cheraqpour
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.